Skip to content
Application 125522
- Type
- BLA
- Sponsor
- AMGEN INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | REPATHA | EVOLOCUMAB | INJECTABLE;INJECTION | 140MG/ML | Yes | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 55513-750 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-750 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-750 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-750 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-750 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-750 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-750 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-750 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-750 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-750 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-750 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-750 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-760 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-760 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-760 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-760 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-760 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-760 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-760 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-760 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-760 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-760 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-760 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-760 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-770 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-770 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-770 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-770 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-770 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-770 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-770 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-770 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-770 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-770 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-770 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 55513-770 | REPATHA | Evolocumab | Amgen Inc | BLA | Current |
| 72511-750 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-750 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-750 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-750 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-750 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-750 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-750 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-750 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-750 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-750 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-750 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-750 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-760 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-760 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-760 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-760 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-760 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-760 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-760 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-760 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-760 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-760 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-760 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-760 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-770 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-770 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-770 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-770 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-770 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-770 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-770 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-770 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-770 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-770 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-770 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |
| 72511-770 | REPATHA | Evolocumab | Amgen USA Inc. | BLA | Current |